Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (567)	3/27/2002 10:39:43 AM
From: keokalani'nui	Read Replies (1) \| Respond to of 1169

Advances in Kinase Inhibitors to Highlight Day 1 at Inflammation in Drug Discovery & Development Meeting, June 24-25 Princeton, NJ PRINCETON, N.J., March 27 /PRNewswire/ -- The world inflammatory disease research community will be convening in Princeton, NJ to attend, speak, and exhibit at ``Inflammation in Drug Discovery & Development,'' announces Strategic Research Institute. This conference will explore in detail -- research efforts to discover and develop safer and more effective therapies of rheumatoid arthritis and other inflammatory diseases & programs intended to generate next generation anti-inflammatory drugs. The conference is organized into 4 main sections: 1) Novel Anti-TNF Proteins, 2) Advances in Small Molecule Anti-TNF Inhibitors, 3)IL-1 Receptors & Receptor Antagonists & 4) Additional Approaches for Novel Anti-Inflammatory Drugs. Featured topics on program include TNF blockers, BAFF, TACE Inhibitors, IRAK, p38 Kinase Inhibitors, Kineret, JNK Inhibitors, ICE, Traps, IKK, IL-2 Receptor Antibody, NFkB Pathway, etc. Participants include: Abbott Laboratories, Amgen, Biogen, Celgene, Immunex, Merck Research Labs, National Institutes of Health, Nereus Pharmaceuticals Pharmacia Corporation, Pfizer Global R & D -- Groton Labs, Protein Design Labs, Regeneron Pharmaceuticals, Roche Bioscience Johnson & Johnson PRI, Scios Inc., Temple University, Vertex Pharmaceuticals, & Wyeth Research II. To request the agenda, please contact Ed Drilon at edrilon@srinstitute.com or 212-967-0095 x233. Include your fax number, affiliation and mailing address. To register for the exposition or inquire about sponsorship opportunities to augment your company's on-site exposure to prospective clients and collaborators (totebags, coffee mugs, luncheons, reception), please contact Mark Alexay at malexay@srinstitute.com. SOURCE: Strategic Research Institute